The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Objective To determine if there is a difference in the risk of endophthalmitis after an intravitreal steroid injection compared to an anti-vascular endothelial growth factor agent (anti-VEGF) injection Design Retrospective cohort study Participants 75,249 beneficiaries in a large national US medical claims database representing 406,380 intravitreal injections Methods Data were searched for all intravitreal injections (CPT 67028) performed between 2003 and 2012. Cohorts were created based on injections using anti-VEGF agents (bevacizumab, ranibizumab, aflibercept and pegaptanib) and intraocular steroids (triamcinolone and dexamethasone). Endophthalmitis was defined as having a new endophthalmitis diagnosis (ICD9 360.0×) and either a “tap-and-inject” procedure (CPT67015, 67025), a vitrectomy (67036) or an intravitreal antibiotic injection on the same day, between 1 and 14 days post-injection. Exclusion occurred for any history of endophthalmitis, <6 months in the plan or <1 month follow up. The main outcome measure was the odds of endophthalmitis using logistic regression while controlling for injection-associated diagnosis, age, race and gender. Results 387,714 anti-VEGF injections and 18,666 steroid intravitreal injections were performed and were followed by 73 (rate=0.019% or 1/5283 anti-VEGF injections) and 24 (rate= 0.13% or 1/778 steroid injections) cases of endophthalmitis respectively. After controlling for diagnosis, age, race and gender, the odds ratio for endophthalmitis occurring was 6.92 (95% CI: 3.54–13.52, p<0.001) times higher post-steroid injection compared to anti-VEGF injections. Conclusions The rate of endophthalmitis post-intravitreal steroid injection in a national cohort was 0.13% (1/778 injections). This rate conferred a significantly increased odds ratio of 6.92 for endophthalmitis compared to anti-VEGF agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS
PEYMAN, G. A., LAD, E. M., & MOSHFEGHI, D. M. (2009) · Retina · doi:10.1097/iae.0b013e3181a94f01 · Cited by 255
Holekamp, N. M., Liu, Y., Yeh, W.-S., Chia, Y., Kiss, S., Almony, A., & Kowalski, J. W. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2013.12.018 · Cited by 88
Cited by
Bacterial and Fungal Endophthalmitis
Durand, M. L. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00113-16 · Cited by 520
Complications of intravitreal injections: 2022
Patel, D., Patel, S. N., Chaudhary, V., & Garg, S. J. (2022) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000850 · Cited by 92
Ruiz-Moreno, J. M., Arias, L., Abraldes, M. J., Montero, J., Udaondo, P., & The RAMDEBURS study group (2021) · International Ophthalmology · doi:10.1007/s10792-021-01906-x · Cited by 41
Complement inhibitors for age-related macular degeneration
Tzoumas, N., Riding, G., Williams, M. A., & Steel, D. H. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009300.pub3 · Cited by 38
Metadata
- Authors
- VanderBeek, B. L., Bonaffini, S. G., & Ma, L.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 122
- Issue
- 11
- Pages
- 2311-2315.e1
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W1897954975
- Cited by
- 97
- References
- 2
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.